Transient anti-NMDAR encephalitis in a newborn infant due to transplacental transmission
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 25, 2015
- Accepted in final form May 14, 2015
- First Published June 18, 2015.
Author Disclosures
- Michelle Hilderink, MD,
- Maarten J. Titulaer, MD, PhD,
- Marco W.J. Schreurs, PhD,
- Koos Keizer, MD, PhD and
- Jan Erik H. Bunt, MD, PhD
- Michelle Hilderink, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Maarten J. Titulaer, MD, PhD,
(1) Serve on the scientific advisory board of MedImmune LLC.
NONE
(1) Sun Pharma, travel grant for lecturing in India
(1) Neurology: Neuroimmunology & Neuroinflammation, since June 2014
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) supported by the Netherlands Organisation for Scientific Research (NWO, Veni incentive)
(1) Currently supported by an ErasmusMC fellowship
(1) supported by the Dutch Epilepsy Foundations, projectnumber 14-19.
NONE
NONE
NONE
NONE
NONE
NONE
- Marco W.J. Schreurs, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Koos Keizer, MD, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jan Erik H. Bunt, MD, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Pediatrics (M.H., J.E.H.B.) and Department of Neurology (K.K.), Catharina Hospital, Eindhoven, the Netherlands; Department of Neurology (M.J.T.) and Department of Immunology (M.W.J.S.), Erasmus Medical Center, Rotterdam, the Netherlands; and Department of Pediatrics (J.E.H.B.), Elisabeth-TweeSteden, Tilburg, the Netherlands.
- Correspondence to Dr. Hilderink: michelle.hilderink{at}catharinaziekenhuis.nl
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Pregnancy outcomes in anti-NMDA receptor encephalitisCase seriesBastien Joubert, Anna García-Serra, Jesús Planagumà et al.Neurology: Neuroimmunology & Neuroinflammation, January 16, 2020 -
Article
Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitisFranziska Scheibe, Harald Prüss, Annerose M. Mengel et al.Neurology, December 21, 2016 -
Special Article
NMDA receptor encephalitis and other antibody-mediated disorders of the synapseThe 2016 Cotzias LectureJosep Dalmau et al.Neurology, December 05, 2016 -
Article
Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodiesEugenia Martinez-Hernandez, Mar Guasp, Anna García-Serra et al.Neurology, March 11, 2020